SCHEMBL31269325

SCHEMBL31269325

CC1(Oc2ncnc3c2nc(-c2ccc(OCCC(=O)O)cc2Cl)n3Cc2cccc(C(F)(F)F)c2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 5/20 0.39
▸ S1PR5 Q9H228 5/20 0.39
▸ PDGFRA P16234 2/20 0.39
▸ PIM1 P11309 1/20 0.39
▸ PRKD3 O94806 1/20 0.36
▸ CDK7 P50613 1/20 0.36
▸ JAK3 P52333 1/20 0.36
▸ TNK2 Q07912 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ THRA P10827 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ RXRA P19793 1/20 0.36
▸ RXRB P28702 1/20 0.36
▸ RXRG P48443 1/20 0.36
▸ FFAR4 Q5NUL3 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31321937 0.92 PLA2G2A (0.40) RXRARXRBRXRGPLA2G2APIK3CD
SCHEMBL31269035 0.92 CNR1 (0.36) S1PR5KMT2AFFAR4FFAR1HTR6
SCHEMBL31269288 0.92 PLA2G2A (0.36) S1PR1GAATHRATHRBRXRA
SCHEMBL31268989 0.91 S1PR1 (0.40) S1PR1S1PR5PDGFRAPIM1PRKD3
SCHEMBL31268742 0.91 S1PR1 (0.40) S1PR1S1PR5PDGFRAPIM1PRKD3
SCHEMBL31269340 0.89 S1PR1 (0.36) S1PR1S1PR5PDGFRAKDM4EALDH1A1
SCHEMBL30983523 0.88 PLA2G2A (0.38) FFAR4PLA2G2APIK3CDPTGDR2
SCHEMBL31268992 0.88 CNR1 (0.35) S1PR5KMT2AFFAR4FFAR1HTR6
SCHEMBL30983451 0.87 PLA2G2A (0.38) PLA2G2AALOX5APPIK3CDPTGDR2
SCHEMBL31268807 0.87 S1PR1 (0.36) S1PR1S1PR5PDGFRAPIM1PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
Send feedback